ArticleGels (Basel, Switzerland)2025
Single-Step Engineered Gelatin-Based Hydrogel for Integrated Prevention of Postoperative Adhesion and Promotion of Wound Healing.
Article in Gels (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Gelatin-Based Multifunctional Hydrogels for Sports Injury Repair: Musculoskeletal and Nervous System Perspectives.Gels (Basel, Switzerland) · 2026Review
- Thermo-Sensitive Polymeric Networks for Next-Generation Wound Management: A Review.AAPS PharmSciTech · 2026Review
- Dynamic Fibrous Hydrogels for Stem Cell Homing and In Situ Bone Regeneration.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Postoperative adhesion remains a major clinical challenge, often leading to chronic pain, functional disorders, and recurrent surgeries. Herein, we developed a multifunctional gelatin-polyphenol hydrogel (GPP20) featuring rapid gelation (within 5 min), strong tissue adhesion (lasting > 24 h under physiological conditions), and intrinsic wound healing capacity to achieve integrated prevention of postoperative adhesion. GPP20 was fabricated via dynamic crosslinking between gelatin and tea polyphenol, endowing it with injectability, self-healing, biodegradability, and excellent mechanical properties (shear stress of 14.2 N). In vitro studies demonstrated that GPP20 exhibited effective ROS scavenging (82% ABTS scavenging capability), which protects cells against oxidative stress, while possessing excellent hemocompatibility and in vivo safety. Notably, GPP20 significantly reduced postoperative cecum-abdominal wall adhesions through both physical barrier effects and modulation of inflammation and collagen deposition, demonstrating a comprehensive integrated prevention strategy. Furthermore, in full-thickness wound models, GPP20 accelerated tissue regeneration (85% wound closure rate on day 10) by promoting macrophage polarization toward the M2 phenotype and stimulating angiogenesis, thereby enhancing collagen deposition and re-epithelialization. Collectively, these findings demonstrate that GPP20 integrates anti-adhesion efficacy with regenerative support, offering a facile and clinically translatable strategy for postoperative care and wound healing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.